Expert Perspectives

Stephen Freedland, MD: Hi, I'm Steve Freedland, Professor of Urology at Cedars-Sinai Medical Center in Los Angeles, as well as at the Durham Veterans Affairs (VA) Hospital in Durham, North Carolina. It's my great privilege and honor here today to be with a dear friend, a phenomenal investigator, Professor Neeraj Agrawal, who is a Professor of Medicine and the Director of the GU Medical Oncology Group at Huntsman Cancer Institute of the University of Utah. Welcome to the program, Neeraj. Neeraj A...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're excited to be discussing this week's expanded FDA approval of enzalutamide for nonmetastatic castration-sensitive prostate cancer with biochemical recurrence. I'm joined by Dr. Stephen Freedland, who co-led the study which led to the approval. Dr. Freedland, thanks so much for coming on today. Stephen Freedland, MD: Thanks for having me. It's certainly an exciting time to be here. Oncology Data Advisor: For a little bit of bac...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're having this interview in honor of Pancreatic Cancer Awareness Month. I'm joined by one of our Editorial Board members, Dr. Joe Kalis, who is an Ambulatory Oncology Clinical Pharmacy Specialist at the University of Colorado Health. He's here to discuss some of the challenges related to diagnosis and screening of pancreatic cancer, as well as the ongoing research in these areas. Dr. Kalis, thanks so much for coming on the show t...

Oncology Data Advisor: Hi everyone, and welcome to this latest podcast collaboration between Oncology Data Advisor and MedNews Week. I'm Keira Smith, I'm the Senior Editor at Oncology Data Advisor. We have a pretty exciting episode today planned in honor of Lung Cancer Awareness Month. We'll be discussing some of the global perspectives in lung cancer that everybody brings to the table here. To start off, we'll go around and have everyone introduce themselves. Starting with the OncData side, Dr....

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're having this interview for National Family Caregivers Month, and I'm joined by Megan-Claire Chase. Thanks so much for coming on the show today. Megan-Claire Chase: Thanks again for having me. Oncology Data Advisor: In light of this being National Family Caregivers Month, would you like to start off by sharing what your experience has been with being a caregiver? Ms. Chase: Sure. First of all, my mother is an ovarian cancer surv...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're having this interview in honor of the Great American Smokeout®, which is a day for raising awareness around smoking and sharing resources for people who are trying to take the first step towards quitting. The aspect of this that we're focusing on today is the link between prostate cancer and smoking, and here today to talk about this is one of our Editorial Board members, Dr. Stephen Freedland. Thanks so much for coming on tod...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're excited to be having this interview in honor of National Family Caregivers Month. I'm joined by Maria Badillo, one of our Editorial Board members, who is here to talk more about this from the nursing perspective. Maria, thanks so much for coming on the show today. Maria Badillo, MSN, RN, OCN®, CCRP: Thank you for inviting me, Keira. Oncology Data Advisor: To start off, would you like to introduce yourself and share what you do...

Rahul Banerjee, MD, FACP: Welcome back to Oncology Data Advisor. My name is Rahul Banerjee, and I'm one of the Board Members of Oncology Data Advisor. I'm also an Assistant Professor of Medicine at the Fred Hutchinson Cancer Center in Seattle. Today, it's my pleasure to be joined by Dr. Andrew Yee. Dr. Yee is a Clinical Director for Multiple Myeloma at Massachusetts General Hospital in Boston. He's also an Assistant Professor of Medicine at Harvard Medical School. He specializes in multiple myel...

Oncology Data Advisor® · Lung Cancer Awareness Month With Waqas Haque, Samuel Kareff, & Matthew Hadfield On the first day of Lung Cancer Awareness Month, members of Oncology Data Advisor's Fellows Forum joined forces to share recent research in lung cancer diagnosis and screening, the need to address disparities experienced by patients, and ways to raise awareness for patients, the public, and the health care community throughout the month of November. Hear unique perspectives fro...

Rahul Banerjee, MD, FACP: Hi, everyone. Welcome back to Oncology Data Advisor. My name is Rahul Banerjee. I'm an Assistant Professor of Medicine at the Fred Hutchinson Cancer Center in Seattle, Washington. Today, it's my pleasure to speak with Dr. Shonali Midha to get some updates from the 2023 International Myeloma Society Meeting that took place at the end of September in Athens, Greece. Dr. Midha is a myeloma expert at the Dana-Farber Cancer Institute in Boston, Massachusetts, and an Instruct...

Samuel Kareff, MD, MPH: Hi, everyone. Welcome to the next episode of the Oncology Data Advisor Fellows Forum. Today, I'm joined by Dr. Matthew Hadfield of Brown University. He's finishing his third year of Hematology and Medical Oncology Fellowship, and today we're going to have a continuation of last week's episode discussing educational initiatives and opportunities during fellowship. Welcome, Matt. Matthew Hadfield, DO: Thank you so much, I'm really excited to be talking with you today. Dr. K...

Oncology Data Advisor: Welcome to Oncology Data Advisor. On today's episode for Breast Cancer Awareness Month, we're focusing on misperceptions surrounding metastatic breast cancer. I'm joined by Janie Metsker, who is the Clinical Coordinator and Nurse Navigator at St. Luke's Koontz Center for Advanced Breast Cancer. Janie, thanks so much for coming on the show today. Janie Metsker, RN, BSN, CN-BN: Thank you for having me today. I'm really excited to share this topic with you. I am the Clinical ...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I'm joined by Dr. Brian Slomovitz, who is live from the ESMO meeting. Dr. Slomovitz, thanks so much for coming on today. Brian Slomovitz, MD: Thanks, Keira. Thanks for having me. My name's Brian Slomovitz. I'm a Gynecologic Oncologist in Miami Beach at Mount Sinai Medical Center. In addition, I serve within the Gynecologic Oncology Group (GOG) Partners Group, which is the group that collaborated within GOG to get this trial done. On...

Oncology Data Advisor: Hi everybody, welcome to Oncology Data Advisor. I'm Keira Smith. I'm the Senior Editor at OncData, and today, we're really excited to be hosting this panel discussion in honor of World Cancer Research Day. I have the pleasure of being joined by a few members of our Fellows Forum and Editorial Board. We have Dr. Samuel Kareff, who is the Chief Hematology/Oncology Fellow at the University of Miami Sylvester Cancer Center. We have Maria Badillo, who is the Research Nurse Mana...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I'm joined by Dr. Henry Park, who is the Chief of Thoracic Radiotherapy at Yale School of Medicine, Smilow Cancer Network. Last year, Dr. Park served as faculty for i3 Health's CME/NCPD/CPE–approved activity on Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). Today, he's here to share some updates that have occurred in the field since then, including data presented just this month at the...

Rahul Banerjee, MD, FACP: Welcome to Oncology Data Advisor. My name is Rahul Banerjee. I'm Assistant Professor of Medicine at the Fred Hutchinson Cancer Center in Seattle. September is Blood Cancer Awareness Month and as a result, we're doing several episodes this month around multiple myeloma. Today, it is my honor to speak with Dr. Gurbakhash Kaur about dosing of medications in myeloma—twice-weekly, biweekly, or somewhere in between. Dr. Kaur is an Assistant Professor of Medicine at the Univer...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're having a Fellows Forum interview, and I'm joined by Dr. Matt Hadfield. Thanks so much for coming on today. Matthew Hadfield, DO: Thank you so much for having me. Oncology Data Advisor: To start off, would you like to share a little bit about yourself and what you do and your work? Dr. Hadfield: Yes, I am a third-year Hematology/Oncology Fellow at Brown University in the Legoretta Cancer Center in Providence, Rhode Island. I pr...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I have the pleasure of being joined by one of our Editorial Board members, Dr. Lauren Ghazal. Thanks so much for coming on today. Lauren Ghazal, PhD, FNP-BC: Thanks for having me. Oncology Data Advisor: To start off, would you like to share a little bit of an intro about yourself? Dr. Ghazal: Oh, yes. Hello everyone, my name is Lauren Ghazal. I am currently an Assistant Professor at the University of Rochester and a Family Nurse Pra...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today we have an interview for Breast Cancer Awareness Month, and I'm joined by Dr. Jason Mouabbi. Dr. Mouabbi, thanks so much for coming on the show today. Jason Mouabbi, MD: Thank you for having me. I'm very happy to be here. Oncology Data Advisor: We have a pretty fun session planned today. We're first going to start off with a Q&A session and then go into a myth busting session. To start off, we're going to go over some frequently ...

Oncology Data Advisor: Welcome to Oncology Data Advisor. I'm Keira Smith, and today I have the pleasure of being joined by Molly MacDonald, who is the Founder of Pink Fund. Molly, thank you so much for coming on the show today. Molly MacDonald: Thank you for having me. Oncology Data Advisor: Would you like to start off giving a brief intro about yourself? Ms. MacDonald: Certainly. With respect to the work that I have the privilege to do now, which is mission-based, I was diagnosed at a time of j...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I have the honor of being joined by Dr. Dhodapkar, who is here to discuss the results of a trial presented at the IMS Meeting. Dr. Dhodapkar, thank you so much for coming on today. Madhav Dhodapkar, MD: It's really a pleasure. Again, my name is Madhav Dhodapkar. I'm a Professor of Hematology and Medical Oncology at Emory University. I'm here at the International Myeloma Society meeting in Greece to discuss the results of a clinical ...

Oncology Data Advisor: Would you like to tell us about yourself and your career in research? Waqas Haque, MD: Hey everybody, I'm Waqas. I'm a third-year Internal Medicine Resident at NYU in the Clinical Investigator Track. For medical school, I went to the University of Texas (UT) Southwestern in Dallas, Texas, which is where I grew up. There, I was involved in a project for my dissertation on the financial and clinical utility of Foundation Medicine testing at our institution's cancer center. I...

Oncology Data Advisor: Welcome to Oncology Data Advisor. I'm Keira Smith. Today, we're having this interview in honor of Pain Awareness Month, and I'm joined by Dr. Nida Khan, who is one of our Fellows Forum members, and Dr. Joseph Kalis, who is one of our Editorial Board members. Thank you both so much for coming on the show today. Nida Khan, MD: Thank you, thanks for having us. Joseph Kalis, PharmD, BCOP: Yes, you're very welcome. I'm excited to be here. Oncology Data Advisor: Would you both l...

Stephen Freedland, MD: Thank you so much for joining us, everyone. I'm Steve Freedland. I'm a Urologist at Cedars-Sinai Medical Center in Los Angeles, as well as at the Durham VA Hospital in Durham, North Carolina. Thank you for joining us on Oncology Data Advisor for Prostate Cancer Awareness Month. I'm super excited that we have a great special guest here, Dr. Farnoosh Nik-Ahd. Dr. Farnoosh Nik-Ahd is a Resident in Urology at UCSF. She went to medical school at the University of California, Lo...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I have the pleasure of being joined by Dr. Jesus Garcia. Thanks so much for coming on today. Jesus Garcia, PhD: Thank you. Oncology Data Advisor: Would you like to introduce yourself and share a little bit about what your work and your research focus on? Dr. Garcia: Sure. So, I'm originally from Mexico. That's where I went to college. I originally came to the United States for grad school. I did all my research in collaboration with...

Oncology Data Advisor: Welcome to Oncology Data Advisor. I'm Kera Smith, and today I'm joined by Dr. Reid Merryman. Dr. Merryman, it's nice to talk to you again. Reid Merryman, MD: Great to be here. Oncology Data Advisor: So, last month, we talked about therecent approval of epcoritamab for diffuse large B-cell lymphoma (DLBCL). Recently, results were also presented for epcoritamab for follicular lymphoma. What is this trial investigating in comparison to the trial that the approval was based on...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're at the ASCO Annual Meeting, and I'm joined by Dr. Kohei Shitara. Thanks so much for coming on today. Dr. Shitara: My pleasure. Oncology Data Advisor: Would you like to introduce yourself and share what your work focuses on? Dr. Shitara: At this ASCO, I'm presenting two posters. One is the prevalence data of claudin 18.2 (CLDN18.2) in gastric cancer patients during two phase 3 trials, and the second is a trial in progress, a ph...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Nicholas Philips. Thanks so much for joining me today. Nicholas Phillips, MD: Nice to meet you, and nice to be here. My name is Nick Philips. I'm a Physician Scientist at St. Jude Children's Research Hospital in the Department of Epidemiology and Cancer Control, and I'm here at ASCO to present my poster. Oncology Data Advisor: Yes, your poster here is on accelerated brain ...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Puneeth Indurlal. Thanks so much for coming on today. Puneeth Indurlal, MD: Thank you for having me. Oncology Data Advisor: Would you like to introduce yourself and share what your work and your research focus on? Dr. Indurlal: My name is Dr. Puneeth Indurlal. I'm a Senior Director for Care Transformation at the US Oncology Network. We've been focusing a lot on value-based...

Nicholas Robert, MD: My name is Nicholas Robert, the Chief Medical Officer for Ontada. Ontada is a McKesson company that's involved with data analytics in technology in the oncology space. Oncology Data Advisor: Today, we're talking about your study here at ASCO on social determinants of health. Would you like to tell us about the study? Dr. Robert: A little bit more than a year ago, Ontada decided that we wanted to give our physicians and our network, the US Oncology Network, the ability to do ...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Michael Halpern. Thanks so much for coming on today. Michael Halpern, MD: Thank you for inviting me. Oncology Data Advisor: Would you like to introduce yourself and share what your work and your research focus on? Dr. Halpern: Sure, my name is Michael Halpern. I'm a Medical Officer at the National Cancer Institute (NCI) in the Healthcare Delivery Research Program, which is...

Samuel Kareff, MD, MPH: Hello, and welcome to this episode of Oncology Data Advisor's Fellows Forum. This is a new resource featuring expert perspectives geared towards Hematology and Medical Oncology Fellows. Today, I'm humbled to be joined by Dr. Ana Velazquez Mañana. She carries several titles, a few of which I'll mention here. She's an Assistant Professor of Medicine in the UCSF Division of Hematology-Oncology at Zuckerberg San Francisco General. She's a Thoracic Oncologist at the UCSF Helen...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Stephanie Smith. Thank you so much for coming on today. Stephanie Smith, MD: Thanks for the invite. Oncology Data Advisor: Would you like to introduce yourself and share what your work focuses on? Dr. Smith: Absolutely. My name is Stephanie Smith. I'm a Pediatric Oncologist and Cancer Survivorship Researcher at Stanford. My research focuses on the intersections between onc...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Richard Newcomb. Thanks much for coming on. Richard Newcomb, MD: Yes, thanks for having me. Oncology Data Advisor: You're presenting a poster here about uncertainty and coping in patients with newly diagnosed indolent non-Hodgkin's lymphoma. To start off, could you tell us a little bit about indolent NHL and why you chose to study this patient population? Dr. Newcomb: As b...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Janet Espirito. Thank you so much for joining me today. Janet Espirito, PharmD: Thank you for having me. Oncology Data Advisor: So, you have an abstract here titled Real-World Response End Points in Patients With Metastatic NSCLC Treated With Chemotherapy Across Real-World Data Sets. What was the background of this study, and why did you decide to investigate this? Dr. Espirit...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Mandy Pratt-Chapman. Thanks so much for coming on today. Mandi Pratt-Chapman, PhD: Absolutely. Oncology Data Advisor: Would you like to introduce yourself and share a little bit about what your work and your research focus on? Dr. Pratt-Chapman: I am an Associate Professor of Medicine at the George Washington University Cancer Center and School of Medicine. I am Associate Cent...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Pant. Thank you so much for joining. Shubham Pant, MD: Thank you. Oncology Data Advisor: I'm interested to hear more about the results of the HERIZON-BTC-01 trial that you are presenting. Would you like to give us an overview and some background about this trial? Dr. Pant: Yes, so this was a global phase 2b trial done in HER2-positive patients with biliary tract cancers. I...

Richa Thakur, MD: Hi, I'm Richa Thakur. I'm a first-year Hematology/Oncology (Heme/Onc) Fellow at Northwell, and I'm one of the members of the Fellows Forum. Today, I'm really excited to introduce you to Dr. Nida Khan. She's a third-year Medicine Resident at Northwell as well, and in July, she's going to be starting her first year of a joint Medical Oncology and Palliative Care Fellowship in Ohio. I'm really excited to bring her, because these programs are so new, and I really can't wait for you...

Oncology Data Advisor® · Understanding and Improving Quality of Life for Cancer Patients Through Nursing Research Following the recent 48th Oncology Nursing Society (ONS), Terri Armstrong, the Senior Investigator and Deputy Chief of the Neuro-Oncology Branch at the National Institutes of Health (NIH), sat down with Oncology Data Advisor® to further discuss her translational research regarding better understanding and improving the quality of life of cancer patients.   Oncology Da...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Darya Kizub. Thank you so much for coming on today. Darya Kizub, MD: Thank you for inviting me. Oncology Data Advisor: So, you're about to present your poster about connecting Black families in Houston, Texas, to hereditary cancer genetic counseling and testing. Would you like to give a little bit of background about why you decided to investigate this? Dr. Kizub: Yes. So,...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Jason Westin. Thank you so much for coming on today. Jason Westin, MD: I'm happy to be here. Thanks for having me. Oncology Data Advisor: Would you like to introduce yourself and share what your work focuses on? Dr. Westin: Of course. I'm Dr. Jason Westin from MD Anderson Cancer Center in Houston, Texas. I'm the Director of Lymphoma Clinical Research and the Section Chief ...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Dr. Deepa Rangachari. Thanks so much for coming on today. Deepa Rangachari, MD: Keira, thanks so much for the invitation. Again, my name is Deepa Rangachari. I am the Director of Hematology/Oncology (Heme/Onc) Graduate Medical Education and the Hematology/Oncology Fellowship Program at the Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. I'm really deligh...

Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today, I'm joined by Dr. Reid Merryman from Dana-Farber Cancer Institute, who is a primary investigator of the EPCORE NHL-1 trial that recently led to the approval of epcoritamab for diffuse large B-cell lymphoma. Dr. Merryman, thank you so much for joining today. To start off, would you like to introduce yourself and share what your work focuses on? Reid Merryman, MD: My name's Reid Merryman. I'm one of the lymphoma docto...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual meeting, and I'm joined by Dr. Aamir Ehsan and Dr. Bridget Herschap from CorePath Laboratories. Thank you both so much for coming on today. Would like to introduce yourselves and share what you do at CorePath? Aamir Ehsan, MD: This is Dr. Aamir Ehsan. I'm the CEO and Medical Director of CorePath Laboratories in San Antonio, Texas. Bridget Herschap, MD: This is Dr. Bridget Herschap. I'm the Medical Direc...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today we're here at the ASCO Annual Meeting, and I'm joined by Cassy Horton. Thanks so much for coming on today. Cassy Horton: I'm very happy to be here. Oncology Data Advisor: Would you like to introduce yourself and share how you became involved with Pickles Group? Cassy Horton: Sure. So my name's Cassy Horton. I'm the Executive Director of Pickles Group. I come from a nonprofit and youth services background, so I've really built a caree...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASCO Annual Meeting, and I'm joined by Barb Kunz. Thanks so much for coming on today. Barb Kunz: Thanks for having us. Oncology Data Advisor: Would you like to introduce yourself and share what your work and your research focus on? Ms. Kunz: My name is Barb Kunz, and I'm a genetic counselor with the US Oncology Network. I was part of a study that Ontada sponsored, that six of our practices that have genetics progra...

Oncology Data Advisor: Welcome to Oncology Data Advisor. I'm Keira Smith, and today I have the pleasure of being joined by Dr. Christine Ko, who is the host of the See, Hear, Feel podcast. Dr. Ko, thank you so much for coming on the show today. Christine Ko, MD: Thank you, Keira. Thanks for having me. Oncology Data Advisor: Would you like to introduce yourself and what your work and research focus on? Dr. Ko: Sure. I'm a Professor of Dermatology and Pathology at Yale University. Dermatology, for...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today we're here at ONS Congress and I'm joined by Susan Rux. Thanks so much for coming on today. Susan Rux, PhD, RN, ACNS-BC®, CNE®: Thanks so much for having me. Oncology Data Advisor: Would you like to introduce yourself and share what you do? Dr. Rux: Sure, sure. I'm Dr. Susan Rux. I am one of the Associate Vice Presidents and I work at Temple University Health System. I'm in charge of nursing education, professional development, and p...

Oncology Data Advisor: Welcome to the Oncology Data Advisor Fellows Forum. Today I have the pleasure of being joined by Dr. Richa Thakur, who is a Palliative Care Physician and a Hematology/Oncology Fellow at Zucker School of Medicine at Hofstra/Northwell Health. Dr. Thakur, thank you so much for coming on today. Richa Thakur, MD: Oh, thank you so much for having me. I'm really excited to be here. Oncology Data Advisor: Would you like you to introduce yourself and share what your work focuses on...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today we're here at ONS Congress, and I'm joined by Maria Badillo, who is on our Editorial Board. Thanks so much for coming on today, Maria. Maria Badillo, MSN, RN, OCN®, CCRP: Good morning, thank you for inviting me here today. I'm Maria Badillo. I'm a Research Nurse Manager at MD Anderson Cancer Center. Oncology Data Advisor: Awesome. How is it being back in person at ONS this year? Ms. Badillo: Oh, it's great. It's great to see people a...

Oncology Data Advisor® · Aligning Treatment Goals and Value-Based Care in Multiple Myeloma With Joseph Kalis, PharmD In this exclusive interview recorded with the Pharmacy Podcast Network, Dr. Joseph Kalis, an Ambulatory Oncology Clinical Pharmacy Specialist at the University of Colorado Health, shares an insightful preview of his continuing pharmacy education (CPE)–accredited activity on newly diagnosed multiple myeloma developed with i3 Health, as well as the potential for empo...

Oncology Data Advisor® · Creating Welcoming Spaces for LGBTQ+ Cancer Survivorship Care At the 48th Annual Oncology Nursing Society (ONS) Congress, Dr. Megan Mullins, an Assistant Professor at the University of Texas (UT) Southwestern Cancer Center, gave a presentation on improving cancer survivorship for sexual and gender minorities. In this follow-up interview, she shares the ongoing efforts into improving cancer survivorship care for these populations, as well as advice and resource...

Oncology Data Advisor: In this month of May dedicated to nurses, we have a very inspiring nurse practitioner with us today at Oncology Data Advisor: Dr. Lauren Ghazal, a Family Nurse Practitioner and a Post-Doctoral Research Fellow at the University of Michigan. Her research on work-related challenges and financial toxicity in adolescent and young adult cancer survivors is funded by the National Cancer Institute. Lauren is a cancer survivor, and she is the author of editorial articles featured o...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at ONNS Congress, and I'm joined by Colleen Stoner and Diane Haley. Thank you both so much for coming on today. Colleen Stoner: Thank you. Diane Haley, LCSW: We are so happy to be with you. Oncology Data Advisor: Would you both like to introduce yourselves and share what you do? Ms. Haley: I'm Diane Haley. I am Director of Patient Experience at Rutgers Cancer Institute of New Jersey in New Brunswick, New Jersey. I have be...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I'm here at ONS Congress, and I'm joined by Colette Baudoin. Thanks so much for coming on today. Colette Baudoin, PhD (c), MSN, RN, OCN, CNE: Thank you for inviting me. Oncology Data Advisor: Would you like to introduce yourself and share what your work focuses on? Ms. Baudoin: Sure, so my name is Colette Baudoin. I am full-time faculty at Louisiana State University (LSU) Health Sciences Center and the New Orleans School of Nursing....

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I'm joined by Tony Ellis, who is the Executive Director of the Oncology Nursing Certification Corporation. Thanks so much for coming on today, Tony. Tony Ellis, MSEd, CAE, ICE-CCP: Thanks for having me. Oncology Data Advisor: So, to start off, what is the mission of ONCC? Mr. Ellis: The primary purpose of ONCC is to promote health and safety by validating competence, knowledge, and experience, and by ensuring lifelong learning in on...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at ONS Congress, and I'm joined by Dr. Amanda King. Thanks so much for coming on today. Amanda King, PhD, APNP-BC: Of course, happy to be here. Oncology Data Advisor: Would you like to introduce yourself and share what your work focuses on? Dr. King: Sure, my name is Dr. Amanda King, and I'm a Nurse Scientist at the National Institutes of Health (NIH). I work in the Neuro-Oncology Branch and the Office of Patient-Centered...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I'm here at ONS Congress, and I'm joined by Amy Rettig. Thank you so much for joining me. Amy Rettig, DNP, RN, APRN-BC: Thank you. I'm very happy to be here, Keira. Oncology Data Advisor: Would you like to introduce yourself and share what your work focuses on? Dr. Rettig. Sure, my name is Amy Rettig, and I work as a Mental Health Advanced Practice Registered Nurse at the James Cancer Hospital at The Ohio State University. My work f...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at ONS Congress, and I'm joined by Elizabeth Archer-Nanda and Meagan Dwyer. Thank you both so much for joining me. Elizabeth Archer-Nanda, DNP, PMHCNS-BC: Thanks, Keira. I'm Elizabeth Archer-Nanda. I'm a Psychiatric Clinical Nurse Specialist at Norton Cancer Institute in Louisville, Kentucky, and the Immediate Past President of the American Psychosocial Oncology Society (APOS). Meagan Dwyer, PhD: Yes, thanks so much for h...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at ONS Congress and I'm joined by Nick Escobedo. Thank you so much for coming on today. Nick Escobedo, DNP, RN, OCN, NE-BC: Thank you for having me. Oncology Data Advisor: Would you like to introduce yourself and share what your work is focusing on? Dr. Escobedo: Yes, of course. So, as you said, I am Nick Escobedo, I've been an Oncology Nurse for just about 13 years. I've had various kinds of practice settings in my few y...

Oncology Data Advisor® · Live Podcasts From the 2023 Oncology Nursing Society (ONS) Congress: Part 1 At the 48th Annual Oncology Nursing Society (ONS) Congress in San Antonio, Texas, Oncology Data Advisor had the privilege of interviewing many distinguished nursing speakers about their research. This ONS Congress playlist features podcast conversations on topics including the healing power of therapy dogs, the benefits of virtual reality for patients with cancer, strategies for bolste...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today I'm here at ONS Congress, and I'm joined by Scott Christensen. Thanks so much for joining me. Scott Christensen, DNP, MBA, APRN, ACNP-BC: Thank you very much. I'm happy to be here. Oncology Data Advisor: Would you'd like to introduce yourself and share what your research focus is on? Dr. Christensen: Sure. I work at the University of Utah Health. I am a Nurse Administrator. I'm also an Adjunct with the College of Nursing, and I'm hel...

Oncology Data Advisor: Welcome to the Oncology Data Advisor Fellows Forum, I'm Keira Smith. Today I'm joined by Dr. Sunil Iyer, who is a Chief Hematology/Oncology Fellow at the University of Miami. Dr. Iyer, thank you so much for coming on today. Sunil Iyer, MD: Hi everyone. It's an honor to be here. I'm Sunil Iyer. I'm a third-year Hematology/Oncology Fellow, current Chief Fellow for the next month and a half, at the University of Miami Sylvester Comprehensive Cancer Center in Miami, Florida. I...

Oncology Data Advisor: Welcome to Oncology Data Advisor. I'm Keira Smith. This April, we're excited to be celebrating National Minority Health Month. Today, I'm joined by Dr. Shakira Grant, who will be sharing her research in the field of health care disparities. Dr. Grant, thank you so much for coming on today. Shakira Grant, MBBS: Hi, I'm Dr. Shakira Grant. I'm an Assistant Professor at the University of North Carolina at Chapel Hill. I spend my time primarily engaged in patient-centered resea...

Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today I'm joined by Dr. Lisa Gudenkauf, who is an Applied Research Scientist in Health Outcomes and Behavior at Moffitt Cancer Center. She's here today to discuss her research regarding patient-reported outcomes for prostate cancer, which was recently presented at the ASCO Genitourinary Cancers Symposium. Dr. Gudenkauf, thank you so much for coming on today. Lisa Gudenkauf, PhD: Hi, my name is Lisa Gudenkauf. I'm an Applie...

Oncology Data Advisor™ · Do Accelerated Approvals Really Benefit Patients? With Ravi Parikh, MD, MPP Recently, Ravi Parikh, MD, MPP, an Assistant Professor of Medical Ethics and Health Policy and Medicine at the University of Pennsylvania, Perelman School of Medicine, released a research letter titled, "Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval." In this interview with OncData, he further discusses his resea...

Oncology Data Advisor: Hi everybody. Welcome to Oncology Data Advisor. Today, we're holding a panel discussion with our Editorial Board in honor of Rare Disease Day. I'm joined by our Editor-in-Chief, Dr. Thomas Abrams, who is an Assistant Professor of Medicine at Harvard Medical School and Institute Physician at Dana-Farber Cancer Institute, and he'll be discussing rare gastrointestinal cancers. Dr. Abrams, thanks for joining today. Thomas Abrams, MD: Oh, it's my pleasure. This is really exciti...

Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today, I'm joined by Dr. Ticiana Leal. Last year, Dr. Leal chaired a CME/NCPD activity focused on immunotherapy-based strategies for advanced non–small cell lung cancer. Today, she'll be sharing the updates that have occurred in the field since recording this activity. Thanks so much for joining today, Dr. Leal. To start off, would you like to introduce yourself and tell us about what you do? Ticiana Leal, MD: Hi, I'm Dr. ...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today we're at the ASH Annual Meeting, and I'm here with Dr. Yimer, who is here to talk about his brentuximab vedotin study for advanced-stage classical Hodgkin lymphoma. Thanks so much for joining today. Habte Yimer, MD: Thank you for inviting me. Oncology Data Advisor: So, would you like to tell us a little bit abo...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASH Annual Meeting and I'm here with Dr. Ira Zackon. Thanks so much for joining today. Ira Zackon, MD: It's a pleasure, thank you for having me. Oncology Data Advisor: Would you like to tell us a little bit about yourself and about what you do? Dr. Zackon: Sure. I've been a practicing Hematol...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I'm at the ASH Annual Meeting with Dr. Oluwole, who is here to talk about his research. Thank you for being here. Ola Oluwole, MD: Thank you. Oncology Data Advisor: I believe you have two abstracts here. Would you like to tell us a little bit about these? Dr. Oluwole: Yes, the first abstract I'm going to talk ...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASH Annual Meeting and I'm with Dr. Mitul Gandhi. Thanks so much for being here. Mitul Gandhi, MD: My pleasure. Oncology Data Advisor: Would you like to introduce yourself and tell us about what you do? Dr. Gandhi: Sure, my name is Mitul Gandhi. I'm a Medical Oncologist and Hematologist, part...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASH Annual meeting, and I'm here with Dr. Lee from MD Anderson. Thanks so much for being here. Hun Lee, MD: Thank you so much for this invitation, Keira. Oncology Data Advisor: Would you like to tell us about yourself and your research? Dr. Lee: My name is Hun. I am an Associate Professor at ...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASH Annual Meeting, and I'm here with Dr. Ariela Marshall. Thank you so much for being here. Ariela Marshall, MD: Absolutely. Thanks for the opportunity to talk with you guys. Oncology Data Advisor: I believe you are the Co-Chair of the ASH Women in Hematology Working Group. Would you like to...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today we're here at the ASH Annual Meeting, and I'm here with Dr. Shakira Grant. Thanks so much for being here. Shakira Grant, MBBS: Thank you so much for having me. Oncology Data Advisor: Would you like to tell us a little bit about yourself and about what you do? Dr. Grant: Sure. I am currently an Assistant Profess...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor. Welcome to Oncology Data Advisor. Today I'm here with Dr. Ian Bouligny, who is here to talk about his abstract on health care disparities in AML treatment. Thanks much for being here today. Ian Bouligny, MD: Yes, thank you very much. Thanks for having me, I appreciate it. Oncology Data Advisor: Would you like to tell us a little bit about yourself an...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're at the ASH Annual Meeting, and I'm here with Ronak Mistry and Vivek Patel. Thank you both so much for being here. Ronak Mistry, DO: It's a pleasure to be here, and thank you so much for inviting us. Vivek Patel, MD: Yes, thanks for having us. Oncology Data Advisor: Absolutely. So, would you like to intro...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. I'm Keira Smith, and today, I'm here with Luis Gerardo Rodríguez-Lobato at the ASH Annual Meeting. Thank you so much for being here today. Luis Gerardo Rodríguez-Lobato, MD, PhD: Hello Keira, nice to meet you also. I'm very pleased to be here with you at the ASH meeting. Oncology Data Advisor: Yes. So, tell us about ...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're at the ASH Annual Meeting, and I'm here with Dr. Robert Rifkin. Dr. Rifkin, thank you so much for joining today. Robert Rifkin, MD, FACP: Thank you very much, and I'm delighted to be here. I'm Robert Rifkin, I'm a Medical Oncologist at Rocky Mountain Cancer Centers in Denver, Colorado, and I'm the Diseas...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today we're here at the ASH Annual Meeting, and I'm joined by Dr. Samer Al Hadidi, who's here to talk about two of his studies. Thanks so much for joining today. Samer Al Hadidi, MD, MS, FACP: Thank you for having me. I'm Samer Al Hadidi. I'm an Assistant Professor at the University of Arkansas, where I practice and ...

Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today I'm joined by Dr. Tabernero, who is here to talk about the results of the phase 3 SUNLIGHT trial being presented at the ASCO Gastrointestinal (GI) Cancers Symposium. Dr. Tabernero, thanks so much for joining me today. Josep Tabernero, MD, PhD: Absolutely. My name is Josep Tabernero. I'm a Medical Oncologist based in Barcelona at the Vall d'Hebron Institute of Oncology. My special focus has been always the treatment o...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here at the ASH Annual Meeting, and I'm here with Dr. Chari, who is here to discuss the MonumenTAL-1 study. Thanks so much for being here. Ajai Chari, MD: Thank you for having me. It's a pleasure. Oncology Data Advisor: Would you like to tell us a little bit about yourself and about what you do? Dr. Char...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. We're here at the ASH Annual Meeting today, and I'm with Dr. Luke Walker, who is the Chief Medical Officer of Harpoon Therapeutics. Thanks for joining today. Luke Walker, MD: Thanks so much for having me. Oncology Data Advisor: Would you like to tell us a little bit about yourself and your background? Dr. Walker: Sur...

Oncology Data Advisor™ · Discussing the Relevance of Urine Studies in Myeloma With Kelsey Natsuhara, MD At the recent American Society of Hematology (ASH) Annual Meeting, Kelsey Natsuhara, MD, a Fellow in Hematology and Oncology at the University of California, San Francisco, sat down with Oncology Data Advisor and ConveyMED to discuss her presentation regarding the relevance of urine studies in myeloma patients undergoing transplantation. This podcast episode was recorded live by O...

This podcast episode was recorded live by Oncology Data Advisor and ConveyMED at the 2022 ASH Annual Meeting in New Orleans. Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're at the ASH Annual Meeting, and I'm here with Manni Mohyuddin. Thank you so much for joining today. Manni Mohyuddin, MBBS: The pleasure is mine, thank you. Oncology Data Advisor: So, I know you have a few abstracts here at the meeting. Would you like to tell us about these and give a little overview of th...

Transcript edited for clarity. Any views expressed above are the speaker's own and do not necessarily reflect those of Oncology Data Advisor.  Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today, I have the honor of being joined by Dr. Irving Weissman, a Professor of Pathology and Developmental Biology and the Director of the Institute of Stem Cell Biology and Regenerative Medicine at Stanford University. Recently, Dr. Weissman received the Wallace H. Coulter Awa...

Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today I'm joined by Dr. Shaji Kumar, Professor of Hematological Malignancies at the Mayo Clinic Cancer Center. Dr. Kumar, thank you so much for joining me today. Since the ASH Annual Meeting just happened recently, would you like to tell us about the abstracts that you presented there? Shaji Kumar, MD: One of the abstracts that we have presented was on the long-term follow-up of the MAIA study. That is a phase 3 trial look...

Oncology Data Advisor™ · Additional Advancements in Research: Multiple Myeloma Earlier this year, Dr. Sarah Holstein of the University of Nebraska Medical Center participated in a two-part continuing medical education (CME) activity regarding practice-changing strategies and improved patient outcomes in the treatment of multiple myeloma (MM). With many updates and improvements in the treatment of MM since recording, Dr. Holstein joins OncData to share her knowledge and talk about wh...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today I'm joined by Dr. Brian Koffman, who is the founder of CLL Society. Dr. Koffman, thank you so much for being here today. Brian Koffman, MD: My great pleasure, thank you. Oncology Data Advisor: To start off, would you like to tell us a little bit about yourself and your background and how you came to establish CLL Society? Dr. Koffman: Absolutely, thanks. I'm Dr. Brian Koffman. I'm a retired family doctor, and I was diagnosed in 2005 ...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, I'm here with Dr. Christopher Iannuzzi, who is the Medical Director of Physician Services and the Chair of Oncology at Hartford HealthCare, St. Vincent's Medical Center. Dr. Iannuzzi is the Principal Investigator of an ongoing clinical trial for advanced prostate cancer at Hartford HealthCare, and today he's going to tell us some more about this trial, as well as some other advice for prostate cancer screening in light of Men's Heal...

Rahul Banerjee, MD, FACP: Hi, everyone. Welcome to Oncology Data Advisor, your resource for the multidisciplinary cancer team. My name is Dr. Rahul Banerjee, and I'm on the Editorial Board for Oncology Data Advisor. Today, it is my pleasure to speak with Dr. Meier and Dr. Rubinstein about clonal hematopoiesis in hematologic malignancies as we speak about Blood Cancer Awareness Month. Dr. Meier is a Fellow in the Division of Hematology and Oncology at UNC Chapel Hill. His research interests are i...

Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today I'm here with Dr. Valerie Brutus, who is a Breast Surgical Oncologist at St. Vincent's Medical Center of Hartford HealthCare in Connecticut. Since October is Breast Cancer Awareness Month, I know that one of the areas that you're passionate about is breast cancer in transgender patients. Would you like to talk to us a little bit about the risk factors and the screening recommendations for this population? Valerie Bru...

Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today I'm here with Dr. Elizabeth Stirling Craig, who is the Director of Microvascular Breast Reconstruction at St. Vincent's Medical Center of Hartford HealthCare. Thank you so much for joining us today. Elizabeth Stirling Craig, MD: Sure, my name is Dr. Stirling Craig and I'm currently the Director of Microvascular Breast Reconstruction for the Hartford HealthCare System. My background is that I'm a plastic surgeon who d...

Oncology Data Advisor™ · Blood Cancer Awareness Month: Exploring Patient-Reported Outcomes: Rahul Banerjee and Ajay Major Recently, Dr. Rahul Banerjee, Assistant Professor at the University of Washington and Editorial Board member for Oncology Data Advisor, spoke with Dr. Ajay Major, Assistant Professor at the University of Colorado, in a live interview discussion in honor of Blood Cancer Awareness Month. Dr. Banerjee and Dr. Major engaged in a riveting conversation about the role o...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today I'm speaking with Blanca Ledezma, who is a Nurse Practitioner at the University of California, Los Angeles (UCLA) Santa Monica. Thank you so much for joining us today. Blanca Ledezma, MSN, NP: I'm Blanca Ledezma. I'm a Nurse Practitioner here in Santa Monica at UCLA Outpatient Oncology. I've been a Nurse Practitioner for over 18 years. My focus is thoracic malignancies. I work with both the clinical research and with the standard of ...

Oncology Data Advisor: Welcome to Oncology Data Advisor. I'm Keira Smith. Today I'm here with Dr. Joshua Sasine, who is here to share his advice on caring for patients receiving CAR T-cell therapy. Thank you so much for joining us today. Joshua Sasine, MD, PhD: Sure, I'm a Hematologist-Oncologist and I work at Cedars-Sinai Medical Center. I'm interested in cellular therapies. I routinely do bone marrow transplants and treat patients with CAR T cells. I'm also a physician-scientist, and I have a ...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today I'm here with Dr. Valerie Brutus, a Breast Surgical Oncologist at St. Vincent's Medical Center of Hartford Healthcare in Connecticut. Thank you for joining me today. Valerie Brutus, MD, FACS: Thank you so much for having me. Oncology Data Advisor: Of course. Tell us about this new technology, Magtrace. What is it, and how does it work? Dr. Brutus: Magtrace is a magnetic dye, and when it's injected into the breast, it mimics what brea...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today, we're here doing a live interview in honor of World Lung Cancer Day. I'm joined by Beth Sandy, who's one of our editorial board members, as well as Dr. Corey Langer. Thank you both for joining us. Would you like to introduce yourselves? Beth Sandy, MSN, CRNP: I'm Beth Sandy. I'm a Nurse Practitioner in the Cancer Center at the University of Pennsylvania in Philadelphia, and my primary practice specialty is lung cancer. With me, I ha...

Oncology Data Advisor: Welcome to Oncology Data Advisor. Today I'm here with Dr. Ash Alpert. Thank you so much for joining us. Ash Alpert, MD, MFA: I'm Dr. Ash Alpert. I'm a postdoctoral fellow in health services research at Brown University, and I'm a hematologist and medical oncologist. My research focuses on improving the experiences and outcomes of transgender people with cancer. Oncology Data Advisor: Would you like to tell us a little bit about the two posters that you presented at ASCO re...

Oncology Data Advisor: Welcome to Oncology Data Advisor. I am here with Dr. Ian Krop of Yale University who presented data on the novel HER3-targeting antibody-drug conjugate patritumab deruxtecan in HER3-expressing metastatic breast cancer. Thank you for joining us, Dr. Krop. Ian Krop, MD, PhD: I'm happy to be here. And just so you know, we all call it just HER3-DXd, which is a lot easier to say than patritumab deruxtecan. Oncology Data Advisor: Thank you. Why is there so much excitement about ...